KAUSHIK J DAVE
CIK 1522751 · CEO and Interim CFO · last filed 2017-03-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.88M
Companies
3
Total Filings
12
Lifetime Open-Market Net
-$220.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATNM | CEO and Interim CFO | 88,500 | $1.01 | $89.4K | $20.2K | 4 | 2017-03-16 |
| ANTARES PHARMA, INC. (ATRS) Delisted | Executive Vice President | 313,028 | $5.59 | $1.75M | -$240.8K | 4 | 2013-06-05 |
| AIS | Executive Vice President | 192,594 | $76.82 | $14.80M | $0 | 3 | 2012-05-21 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-13 | AIS | Grant (A) | +16,887 | $0 | EDGAR |
| 2011-09-13 | AIS | Grant (A) | +34,155 | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.